Claudia I Muller

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi Do cancer cells selectively mutate HFE to increase their intracellular iron?
    Claudia I Muller
    Division of Hematology Oncology, Davis 5065, Cedars Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Oncol Rep 14:299-303. 2005
  2. ncbi Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells
    Claudia I Muller
    Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    Leuk Res 30:841-8. 2006
  3. ncbi Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene
    Claudia I Muller
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Leuk Res 31:27-32. 2007
  4. ncbi Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines
    Takashi Kumagai
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Leuk Res 31:523-30. 2007
  5. ncbi RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation
    Sigal Gery
    Division of Hematology Oncology, UCLA School of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Exp Hematol 35:572-8. 2007

Detail Information

Publications5

  1. ncbi Do cancer cells selectively mutate HFE to increase their intracellular iron?
    Claudia I Muller
    Division of Hematology Oncology, Davis 5065, Cedars Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Oncol Rep 14:299-303. 2005
    ..Five cell lines had a heterozygous mutation of HFE, none had a homozygous HFE mutation in the coding region. In summary, our experiments suggest that HFE mutations are not associated with a growth advantage for cancer cells...
  2. ncbi Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells
    Claudia I Muller
    Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
    Leuk Res 30:841-8. 2006
    ..These results indicate that G. lucidum extract has a profound activity against leukemia, lymphoma and multiple myeloma cells and may be a novel adjunctive therapy for the treatment of hematologic malignancies...
  3. ncbi Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene
    Claudia I Muller
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Leuk Res 31:27-32. 2007
    ..Additionally, a previously unidentified PIK3CA pseudogene spanning exons 9-13 on chromosome 22 was discovered...
  4. ncbi Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines
    Takashi Kumagai
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Leuk Res 31:523-30. 2007
    ..HPLC analysis of S.B. showed it contains 21% baicalin and further studies confirmed it was the major anti-cancer component of S.B. Thus, Scutellaria baicalensis should be tested in clinical trials for these hematopoietic malignancies...
  5. ncbi RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation
    Sigal Gery
    Division of Hematology Oncology, UCLA School of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Exp Hematol 35:572-8. 2007
    ..The aim of this study was to identify and characterize retinoic acid (RA) target genes...